Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pushpendra Goswami

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Rheumatology and Therapy|October 10, 2024
The Development and Content Validation of the Sjögren's Related Quality of Life Instrument (SRQoL)Jessica Marvel, Elizabeth Gargon, Chloe Howse, et al.
Frontiers in Pharmacology|March 27, 2020
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content ValidityPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Therapeutic Advances in Hematology|October 26, 2020
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative studyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Frontiers in Pharmacology|October 5, 2020
Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity StudyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Frontiers in Pharmacology|November 16, 2020
Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PROPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Journal of Comparative Effectiveness Research|May 1, 2019
Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence studyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Annals of the Rheumatic Diseases|June 17, 2025
Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)Simon J Bowman, Raphaele Seror, Raphael Porcher, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Rheumatology and Therapy|October 10, 2024
The Development and Content Validation of the Sjögren's Related Quality of Life Instrument (SRQoL)Jessica Marvel, Elizabeth Gargon, Chloe Howse, et al.
Frontiers in Pharmacology|March 27, 2020
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content ValidityPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Therapeutic Advances in Hematology|October 26, 2020
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative studyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Frontiers in Pharmacology|October 5, 2020
Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity StudyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Frontiers in Pharmacology|November 16, 2020
Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PROPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Journal of Comparative Effectiveness Research|May 1, 2019
Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence studyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Annals of the Rheumatic Diseases|June 17, 2025
Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)Simon J Bowman, Raphaele Seror, Raphael Porcher, et al.
Pageof 2